Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
April 4, 2006
Involvement of adenosine in the neurobiology of schizophrenia and its therapeutic implications
Diogo R Lara, Oscar P Dall'Igna, Eduardo S Ghisolfi, et al.
The Journal of Clinical Psychiatry
|
February 12, 2005
A clinical trial of adjuvant allopurinol therapy for moderately refractory schizophrenia
Miriam G Brunstein, Eduardo S Ghisolfi, Fernanda L P Ramos, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology
|
February 14, 2004
Impaired P50 sensory gating in post-traumatic stress disorder secondary to urban violence
Eduardo S Ghisolfi, Regina Margis, Jefferson Becker, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
March 28, 2003
Neuropsychiatric evaluation in subjects chronically exposed to organophosphate pesticides
Rosane Maria Salvi, Diogo R Lara, Eduardo S Ghisolfi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 16, 2002
The adenosine antagonist theophylline impairs p50 auditory sensory gating in normal subjects
Eduardo S Ghisolfi, Alexandre S Prokopiuk, Jefferson Becker, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
November 10, 2005
Caffeine modulates P50 auditory sensory gating in healthy subjects
Eduardo S Ghisolfi, Alice Schuch, Ivo M Strimitzer, et al.
Journal of Psychiatric Research
|
April 18, 2006
P50 sensory gating in panic disorder
Eduardo S Ghisolfi, Elizeth Heldt, Ana Paula Zanardo, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
January 28, 2004
Clozapine, but not typical antipsychotics, correct P50 suppression deficit in patients with schizophrenia
Jefferson Becker, Irenio Gomes, Eduardo S Ghisolfi, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
September 8, 2004
Impaired P50 sensory gating in Machado-Joseph disease
Eduardo S Ghisolfi, Gustavo H B Maegawa, Jefferson Becker, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
April 4, 2006
Involvement of adenosine in the neurobiology of schizophrenia and its therapeutic implications
Diogo R Lara, Oscar P Dall'Igna, Eduardo S Ghisolfi, et al.
The Journal of Clinical Psychiatry
|
February 12, 2005
A clinical trial of adjuvant allopurinol therapy for moderately refractory schizophrenia
Miriam G Brunstein, Eduardo S Ghisolfi, Fernanda L P Ramos, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology
|
February 14, 2004
Impaired P50 sensory gating in post-traumatic stress disorder secondary to urban violence
Eduardo S Ghisolfi, Regina Margis, Jefferson Becker, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
March 28, 2003
Neuropsychiatric evaluation in subjects chronically exposed to organophosphate pesticides
Rosane Maria Salvi, Diogo R Lara, Eduardo S Ghisolfi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 16, 2002
The adenosine antagonist theophylline impairs p50 auditory sensory gating in normal subjects
Eduardo S Ghisolfi, Alexandre S Prokopiuk, Jefferson Becker, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
November 10, 2005
Caffeine modulates P50 auditory sensory gating in healthy subjects
Eduardo S Ghisolfi, Alice Schuch, Ivo M Strimitzer, et al.
Journal of Psychiatric Research
|
April 18, 2006
P50 sensory gating in panic disorder
Eduardo S Ghisolfi, Elizeth Heldt, Ana Paula Zanardo, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
January 28, 2004
Clozapine, but not typical antipsychotics, correct P50 suppression deficit in patients with schizophrenia
Jefferson Becker, Irenio Gomes, Eduardo S Ghisolfi, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
September 8, 2004
Impaired P50 sensory gating in Machado-Joseph disease
Eduardo S Ghisolfi, Gustavo H B Maegawa, Jefferson Becker, et al.
Page
of 1